Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort-term InvestmentsWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Receivables: 2020-2024

Historic Receivables for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to $29.0 million.

  • Burning Rock Biotech's Receivables rose 8.85% to $25.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.8 million, marking a year-over-year increase of 8.85%. This contributed to the annual value of $29.0 million for FY2024, which is 9.55% up from last year.
  • Burning Rock Biotech's Receivables amounted to $29.0 million in FY2024, which was up 9.55% from $26.5 million recorded in FY2023.
  • In the past 5 years, Burning Rock Biotech's Receivables registered a high of $29.0 million during FY2024, and its lowest value of $20.7 million during FY2020.
  • For the 3-year period, Burning Rock Biotech's Receivables averaged around $27.9 million, with its median value being $28.2 million (2022).
  • Per our database at Business Quant, Burning Rock Biotech's Receivables soared by 31.82% in 2021 and then fell by 6.16% in 2023.
  • Burning Rock Biotech's Receivables (MRY) stood at $20.7 million in 2020, then surged by 31.82% to $27.3 million in 2021, then increased by 3.49% to $28.2 million in 2022, then decreased by 6.16% to $26.5 million in 2023, then grew by 9.55% to $29.0 million in 2024.
  • Its Receivables was $29.0 million in FY2024, compared to $26.5 million in FY2023 and $28.2 million in FY2022.